The generic version of Teflaro could be released after February 10, 2031, when the last patent (US8247400) expires. This patent, titled 'Cephem compounds useful for the treatment of bacterial infections', protects the active compound used in Teflaro.
Teflaro is used for treating a variety of bacterial infections. Its active ingredient, ceftaroline fosamil, works by inhibiting bacterial cell wall synthesis, thereby stopping the growth of bacteria.
Teflaro holds a total of 3 drug patents, of which 1 has already expired. The remaining patents protect the drug from generic competition until at least February 2031. For more about when Teflaro generic could be available, see the patent expiry plot below. Below are the details of the patent: